Obidoxime in acute organophosphate poisoning: 1 – clinical effectiveness

References

• Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006; 368:2136–2141.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Eyer P, Worek F, Juszczak E, Adler N, Mohamed F, Senarathna L, Hittarage A, Azher S, Jeganathan K, Jayamanne S, von Meyer L, Dawson AH, Sheriff MH, Buckley NA. Pralidoxime in acute organophosphorus insecticide poisoning – a randomised controlled trial. PLoS Med 2009; 6:e1000104.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Abdollahi M. Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 2006; 25:157–162.
   PubMed Web of Science ®Google Scholar
• Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006; 34:502–510.
   PubMed Web of Science ®Google Scholar
• Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003; 22:165–190.
   PubMedGoogle Scholar
• Brahmi N, Mokline A, Kouraichi N, Ghorbel H, Blel Y, Thabet H, Hedhili A. Amamou M. Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning. Am J Emerg Med 2006; 24:822–827.
   PubMed Web of Science ®Google Scholar
• Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 1997; 16:473–480.
   PubMed Web of Science ®Google Scholar
• Singh G, Mahajan R, Whig J. The importance of electrodiagnostic studies in acute organophosphate poisoning. J Neurol Sci 1998; 157:191–200.
   PubMed Web of Science ®Google Scholar
• Besser R, Weilemann LS, Gutmann L. Efficacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies. Muscle Nerve 1995; 18:15–22.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005; 366:1452–1459.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 2002; 95:275–283.
   PubMed Web of Science ®Google Scholar
• Eyer F, Eyer P. Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients. Hum Exp Toxicol 1998; 17:645–651.
   PubMed Web of Science ®Google Scholar
• Willems JL, De Bisschop HC, Verstraete AG, Declerck C, Christiaens Y, Vanscheeuwyck P, Buylaert WA, Vogelaers D, Colardyn F. Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate. Arch Toxicol 1993; 67:79–84.
   PubMed Web of Science ®Google Scholar
• Eyer F, Roberts DM, Buckley NA, Eddleston M, Thiermann H, Worek F, Eyer P. Extreme variability in the formation of chlorpyrifos oxon (CPO) in patients poisoned by chlorpyrifos (CPF). Biochem Pharmacol 2009; 78:531–537.
   PubMed Web of Science ®Google Scholar
• Casey PB, Gosden E, Blakely L, Thompson JP, Vale JA. Plasma pralidoxime concentrations following bolus injection and continuous infusion. Przeglad Lekarski 1995; 52:203.
   Google Scholar
• Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999; 288:73–90.
   PubMed Web of Science ®Google Scholar
• Spöhrer U, Eyer P. Separation of geometrical syn/anti isomers of obidoxime by ion-pair high-performance liquid chromatography. J Chrom A 1995; 693:55–61.
   Web of Science ®Google Scholar
• Thiermann H, Radtke M, Spöhrer U, Klimmek R, Eyer P. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7. Arch Toxicol 1996; 70:293–299.
   PubMed Web of Science ®Google Scholar
• Thiermann H, Worek F, Eyer P, Eyer F, Felgenhauer N, Zilker T. Obidoxime in acute organophosphate poisoning: 2 – PK/PD relationships. Clin Toxicol 2009; 47 DOI: 10.1080/15563650903206836.
   Web of Science ®Google Scholar
• Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, Buckley NA. Early management after self-poisoning with an organophosphorus or carbamate pesticide – a treatment protocol for junior doctors. Crit Care 2004; 8:R391–R397.
   PubMed Web of Science ®Google Scholar
• Zilker T, Hibler A. Treatment of severe parathion poisoning. In: Szinicz L, Eyer P, Klimmek R, eds. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. Heidelberg: Spektrum, Akademischer Verlag; 1996:9–17.
   Google Scholar
• Eddleston M, Eyer P, Worek F, Sheriff MH, Buckley NA. Predicting outcome using butyrylcholinesterase activity in organophosphorus pesticide self-poisoning. QJM 2008; 101:467–474.
   PubMed Web of Science ®Google Scholar
• Eyer F, Meischner V, Kiderlen D, Thiermann H, Worek F, Haberkorn M, Felgenhauer N, Zilker T, Eyer P. Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 2003; 22:143–163.
   PubMedGoogle Scholar
• Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316:761–763.
   PubMed Web of Science ®Google Scholar
• Lotti M. Clinical toxicology of anticholinesterase agents in humans. In: Krieger RI, ed. Handbook of Pesticide Toxicology. Vol. 2. San Diego, CA: Academic Press; 2001:1043–1085.
   Google Scholar
• De Bleecker J, Van den Neucker K, Colardyn F. Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit Care Med 1993; 21:1706–1711.
   PubMed Web of Science ®Google Scholar
• Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, Buckley NA, Senanayake N. The spectrum of intermediate syndrome following acute organophosphate poisoning: a prospective cohort study from Sri Lanka. PLoS Med 2008; 5:e147.
   PubMed Web of Science ®Google Scholar
• Boelcke G, Creutzfeldt W, Erdmann WD, Gaaz JW, Jacob G. Studies on liver toxicity of obidoxim (Toxogonin) in humans. Dtsch Med Wochenschr 1970; 95:1175–1178.
   PubMed Web of Science ®Google Scholar
• Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale A, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg. Med 2000; 12:22–37.
   Google Scholar
• Eyer P, Szinicz L, Thiermann H, Worek F, Zilker T. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality. Toxicology 2007; 233:108–119.
   PubMed Web of Science ®Google Scholar
• Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007; 233:145–154.
   PubMed Web of Science ®Google Scholar